Eckert & Ziegler: First patient enrolment for SOMscan®
OctreoPharm Sciences GmbH, a development company for radiopharmaceuticals, treated its first patients in a Swiss univer…
OctreoPharm Sciences GmbH, a development company for radiopharmaceuticals, treated its first patients in a Swiss univer…
"Join Together for Better Care" is the slogan of Rare Disease Day, which will be held on February 28. EURORDIS (European…
In cooperation with the Miller Theatre New York the Forum of Contemporary Music Leipzig [FZML] proudly presents a concer…
The Berlin company Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope applic…
The first quarter of 2011 was extremely successful for the Eckert & Ziegler Group (ISIN DE0005659700), a specialist for…
The Berlin company Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope techno…
The physicist Dr. Gudrun Erzgräber, member of the Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG,…
Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a firm specializing in medical use of…
The Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for radioactivity in…
The Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) announces that the acceptance period for the ma…